The authors also completed a post hoc study, showing that patients with lower SV2A density at baseline may exhibit an increased SV2A density 24 h after ketamine administration, coherent with the reduction in severity of depression (Holmes et al., 2022). This evidence concerns the gene SV2A and major depressive disorder.